AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2021
Jan 19, 2021
30610_dirs_2021-01-19_329b3b9d-f11f-4100-a8a2-6a9311e5887e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-01-19
Reporting Person: Le Goff Corinne (Chief Commercial Officer)
More from Moderna, Inc.
Regulatory Filings
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13